October 2015 Vol 8, No 7

Whatever the reason, I’m more reflective these days than ever. Late spring and early summer in Philadelphia was a time for more reflection as our city hosted both the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and The Bio International Convention (BIO) 2015 meeting.
After more than 2 centuries of work, we now understand more about the cellular biology of rheumatoid arthritis, but the underlying cause of the disease remains elusive.
Closing Gaps in Health Plan Performance with Stakeholder Collaboration
Although varicose veins are considered by some policymakers to primarily be an aesthetic concern, varicosities and their resulting sequelae are primary contributors to the morbidity associated with chronic venous diseases.
A Teachable Moment in Health Benefits Design
The shift in the drug development pipeline to specialty drug domination is transforming the pharmacy benefits industry.
From 1999 to 2008, the utilization rate of total knee replacement procedures in the United States more than doubled for the overall population, and tripled for individuals aged 45 to 64 years.
Knee and Hip Pain: Rewarding Optimal Long-Term Management

Results 1 - 5 of 5
  •  Association for Value-Based Cancer Care
  • Oncology Practice Management
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Rheumatology Practice Management
  • Urology Practice Management
  • Lynx CME